Targeted Auger electron-emitter therapy: Radiochemical approaches for thallium-201 radiopharmaceuticals
Abstract
Thallium-201 is a radionuclide that has previously been used clinically for myocardial perfusion scintigraphy. Although in this role it has now been largely replaced by technetium-99 m radiopharmaceuticals, thallium-201 remains attractive in the context of molecular radionuclide therapy for cancer micrometastases or single circulating tumour cells. This is due to its Auger electron (AE) emissions, which are amongst the highest in total energy...
Paper Details
Title
Targeted Auger electron-emitter therapy: Radiochemical approaches for thallium-201 radiopharmaceuticals
Published Date
Jul 1, 2021
Journal
Volume
98-99
Pages
1 - 7
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History